XML 53 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Share-Based Compensation Expense

The amount of share-based compensation expense recognized by the Company by location in its statements of operations for the three and six months ended June 30, 2020 and 2019 is as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of revenues

 

$

15

 

 

$

19

 

 

$

31

 

 

$

29

 

Sales and marketing

 

 

236

 

 

 

404

 

 

 

666

 

 

 

608

 

General and administrative

 

 

261

 

 

 

479

 

 

 

868

 

 

 

697

 

Research and development

 

 

134

 

 

 

120

 

 

 

277

 

 

 

189

 

Total

 

$

646

 

 

$

1,022

 

 

$

1,842

 

 

$

1,523

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the six months ended June 30, 2020:

 

 

 

Number of

Shares under

Option

(in thousands)

 

 

Weighted-

average

Exercise Price

per Option

 

 

Weighted-

average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Outstanding at December 31, 2019

 

 

2,415

 

 

$

7.11

 

 

 

 

 

 

 

 

 

Granted

 

 

28

 

 

$

2.94

 

 

 

 

 

 

 

 

 

Exercised

 

 

(98

)

 

$

1.28

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(480

)

 

$

11.16

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2020

 

 

1,865

 

 

$

6.31

 

 

 

5.2

 

 

$

527

 

Exercisable at June 30, 2020

 

 

1,312

 

 

$

4.63

 

 

 

3.8

 

 

$

527

 

Vested and expected to vest at June 30, 2020

 

 

1,865

 

 

$

6.31

 

 

 

5.2

 

 

$

527

 

Summary of Weighted-average Inputs and Assumptions used to Estimate Grant-date Fair Value of Stock Options

For the six months ended June 30, 2020, the grant-date fair value of stock options was estimated at the time of grant using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model:

 

Estimated fair value of common stock

 

$

2.94

 

Exercise price

 

$

2.94

 

Expected term (in years)

 

 

6.1

 

Risk-free interest rate

 

 

1

%

Expected volatility

 

 

55

%

Dividend yield

 

 

0

%

Summary of Restricted Stock Award and Restricted Stock Unit Activity

The following table summarizes the Company’s restricted stock award and restricted stock unit activity for the six months ended June 30, 2020:

 

 

 

Non-vested

Restricted

Stock Units

(in thousands)

 

 

Weighted-

average

Grant-date

Fair Value

 

Non-vested at December 31, 2019

 

 

245

 

 

$

15.23

 

Granted

 

 

1,504

 

 

$

3.40

 

Vested

 

 

(66

)

 

$

15.26

 

Forfeited

 

 

(394

)

 

$

5.34

 

Non-vested at June 30, 2020

 

 

1,289

 

 

$

4.45